Review



pd98059  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Tocris pd98059
    Pd98059, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 838 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd+98059/pmc13018835-175-37-38?v=Tocris
    Average 96 stars, based on 838 article reviews
    pd98059 - by Bioz Stars, 2026-06
    96/100 stars

    Images



    Similar Products

    96
    Tocris pd98059
    Pd98059, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd+98059/pmc13018835-175-37-38?v=Tocris
    Average 96 stars, based on 1 article reviews
    pd98059 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    Tocris pd 98059
    Pd 98059, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd+98059/pmc12774701-42-0-3?v=Tocris
    Average 96 stars, based on 1 article reviews
    pd 98059 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    mek1  (Tocris)
    96
    Tocris mek1
    Inhibition of the NF-κB, p38 and JNK pathway components had an effect on the nucleic acid induced chemokine expression of NHEKs. Specific inhibiton of signaling pathway components was obtained by inhibitors (NF-κB (Bay 11−7085, 10 μM); STING (H151, 200 ng/ml); STAT-1 (Fludarabine, 10 μM); STAT-3 (Stattic, 5 μM); <t>MEK1</t> <t>(PD98059,</t> 20 μM); JNK (SP600125, 10 μM) and p38 (SB203580, 10 μM)) for 60 minutes before transfecting the cells with 0,666 μg/mL poly(I:C) or 1 ug/mL poly(dA:dT). Gene expression of fractalkine (A-C), CCL2 (D-F) and CXCL10 (G-I) was determined by the ∆∆Ct method, with GAPDH as a normalizing gene compared to the expression of the nontreated control samples. Data are presented as mean ± SD with individual datapoints, white squares representing poly(I:C), black triangles representing poly(dA:dT) treatment, n = 3. Gene expression differences were analyzed using linear mixed-effects models, p-values were adjusted using the Benjamini-Hochberg method within each solvent group-stimulus combination **** p < 0.0001, *** p < 0.001,** p < 0.01, *p < 0.05.
    Mek1, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd+98059/pmc12633943-36-44-54?v=Tocris
    Average 96 stars, based on 1 article reviews
    mek1 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    Biogems International biogems catalog number 1672186
    Inhibition of the NF-κB, p38 and JNK pathway components had an effect on the nucleic acid induced chemokine expression of NHEKs. Specific inhibiton of signaling pathway components was obtained by inhibitors (NF-κB (Bay 11−7085, 10 μM); STING (H151, 200 ng/ml); STAT-1 (Fludarabine, 10 μM); STAT-3 (Stattic, 5 μM); <t>MEK1</t> <t>(PD98059,</t> 20 μM); JNK (SP600125, 10 μM) and p38 (SB203580, 10 μM)) for 60 minutes before transfecting the cells with 0,666 μg/mL poly(I:C) or 1 ug/mL poly(dA:dT). Gene expression of fractalkine (A-C), CCL2 (D-F) and CXCL10 (G-I) was determined by the ∆∆Ct method, with GAPDH as a normalizing gene compared to the expression of the nontreated control samples. Data are presented as mean ± SD with individual datapoints, white squares representing poly(I:C), black triangles representing poly(dA:dT) treatment, n = 3. Gene expression differences were analyzed using linear mixed-effects models, p-values were adjusted using the Benjamini-Hochberg method within each solvent group-stimulus combination **** p < 0.0001, *** p < 0.001,** p < 0.01, *p < 0.05.
    Biogems Catalog Number 1672186, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd+98059/pmc12643938-327-48-48?v=Biogems+International
    Average 93 stars, based on 1 article reviews
    biogems catalog number 1672186 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    Inhibition of the NF-κB, p38 and JNK pathway components had an effect on the nucleic acid induced chemokine expression of NHEKs. Specific inhibiton of signaling pathway components was obtained by inhibitors (NF-κB (Bay 11−7085, 10 μM); STING (H151, 200 ng/ml); STAT-1 (Fludarabine, 10 μM); STAT-3 (Stattic, 5 μM); MEK1 (PD98059, 20 μM); JNK (SP600125, 10 μM) and p38 (SB203580, 10 μM)) for 60 minutes before transfecting the cells with 0,666 μg/mL poly(I:C) or 1 ug/mL poly(dA:dT). Gene expression of fractalkine (A-C), CCL2 (D-F) and CXCL10 (G-I) was determined by the ∆∆Ct method, with GAPDH as a normalizing gene compared to the expression of the nontreated control samples. Data are presented as mean ± SD with individual datapoints, white squares representing poly(I:C), black triangles representing poly(dA:dT) treatment, n = 3. Gene expression differences were analyzed using linear mixed-effects models, p-values were adjusted using the Benjamini-Hochberg method within each solvent group-stimulus combination **** p < 0.0001, *** p < 0.001,** p < 0.01, *p < 0.05.

    Journal: PLOS One

    Article Title: Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation

    doi: 10.1371/journal.pone.0336901

    Figure Lengend Snippet: Inhibition of the NF-κB, p38 and JNK pathway components had an effect on the nucleic acid induced chemokine expression of NHEKs. Specific inhibiton of signaling pathway components was obtained by inhibitors (NF-κB (Bay 11−7085, 10 μM); STING (H151, 200 ng/ml); STAT-1 (Fludarabine, 10 μM); STAT-3 (Stattic, 5 μM); MEK1 (PD98059, 20 μM); JNK (SP600125, 10 μM) and p38 (SB203580, 10 μM)) for 60 minutes before transfecting the cells with 0,666 μg/mL poly(I:C) or 1 ug/mL poly(dA:dT). Gene expression of fractalkine (A-C), CCL2 (D-F) and CXCL10 (G-I) was determined by the ∆∆Ct method, with GAPDH as a normalizing gene compared to the expression of the nontreated control samples. Data are presented as mean ± SD with individual datapoints, white squares representing poly(I:C), black triangles representing poly(dA:dT) treatment, n = 3. Gene expression differences were analyzed using linear mixed-effects models, p-values were adjusted using the Benjamini-Hochberg method within each solvent group-stimulus combination **** p < 0.0001, *** p < 0.001,** p < 0.01, *p < 0.05.

    Article Snippet: For inhibition studies, cells were incubated for 60 minutes prior to poly(dA:dT)/poly(I:C) transfection with inhibitors for NF-κB (Bay 11−7085, 10 μM; MedChem Express, Monmouth Junction, NJ, USA), STING (H151, 200 ng/ml, InvivoGene) STAT-1 (Fludarabine, 10 μM; Sigma Aldrich), STAT-3 (Stattic, 5 μM; Sigma Aldrich), MEK1 (PD98059, 20 μM; Sigma Aldrich), JNK (SP600125, 10 μM; Tocris Bioscience, Bristol, UK) and p38 (SB203580, 10 μM; Tocris Bioscience).

    Techniques: Inhibition, Expressing, Gene Expression, Control, Solvent